SciGen is pleased to announce a joint partnership with Zuellig Pharma Singapore to extend the distribution footprint of SciGen’s endocrinology and oncology portfolio in Singapore. As SciGen’s exclusive distribution partner, Zuellig Pharma Singapore will enhance patient access to SciGen’s key products such as Zometa®, Growth Hormone Scitropin A® and more in the coming years.
Key attendees in the signing ceremony at Zuellig Pharma office
SciGen: Valery Yeo (CFO), Dr Shazli Khan (VP & Region Head, APAC)
Zuellig Pharma: Tan Yan Ann (Managing Director), Dave Lai (Director)